254 related articles for article (PubMed ID: 20494439)
1. Polyethyleneimine-modified iron oxide nanoparticles for brain tumor drug delivery using magnetic targeting and intra-carotid administration.
Chertok B; David AE; Yang VC
Biomaterials; 2010 Aug; 31(24):6317-24. PubMed ID: 20494439
[TBL] [Abstract][Full Text] [Related]
2. Brain tumor targeting of magnetic nanoparticles for potential drug delivery: effect of administration route and magnetic field topography.
Chertok B; David AE; Yang VC
J Control Release; 2011 Nov; 155(3):393-9. PubMed ID: 21763736
[TBL] [Abstract][Full Text] [Related]
3. Iron oxide nanoparticles as a drug delivery vehicle for MRI monitored magnetic targeting of brain tumors.
Chertok B; Moffat BA; David AE; Yu F; Bergemann C; Ross BD; Yang VC
Biomaterials; 2008 Feb; 29(4):487-96. PubMed ID: 17964647
[TBL] [Abstract][Full Text] [Related]
4. Gum arabic-coated magnetic nanoparticles for potential application in simultaneous magnetic targeting and tumor imaging.
Zhang L; Yu F; Cole AJ; Chertok B; David AE; Wang J; Yang VC
AAPS J; 2009 Dec; 11(4):693-9. PubMed ID: 19842043
[TBL] [Abstract][Full Text] [Related]
5. Magnetic brain tumor targeting and biodistribution of long-circulating PEG-modified, cross-linked starch-coated iron oxide nanoparticles.
Cole AJ; David AE; Wang J; Galbán CJ; Yang VC
Biomaterials; 2011 Sep; 32(26):6291-301. PubMed ID: 21684593
[TBL] [Abstract][Full Text] [Related]
6. Substantiating in vivo magnetic brain tumor targeting of cationic iron oxide nanocarriers via adsorptive surface masking.
Chertok B; David AE; Moffat BA; Yang VC
Biomaterials; 2009 Dec; 30(35):6780-7. PubMed ID: 19782394
[TBL] [Abstract][Full Text] [Related]
7. Magnetically-enabled and MR-monitored selective brain tumor protein delivery in rats via magnetic nanocarriers.
Chertok B; David AE; Yang VC
Biomaterials; 2011 Sep; 32(26):6245-53. PubMed ID: 21632104
[TBL] [Abstract][Full Text] [Related]
8. Polyethylene glycol modified, cross-linked starch-coated iron oxide nanoparticles for enhanced magnetic tumor targeting.
Cole AJ; David AE; Wang J; Galbán CJ; Hill HL; Yang VC
Biomaterials; 2011 Mar; 32(8):2183-93. PubMed ID: 21176955
[TBL] [Abstract][Full Text] [Related]
9. Silica-iron oxide magnetic nanoparticles modified for gene delivery: a search for optimum and quantitative criteria.
Mykhaylyk O; Sobisch T; Almstätter I; Sanchez-Antequera Y; Brandt S; Anton M; Döblinger M; Eberbeck D; Settles M; Braren R; Lerche D; Plank C
Pharm Res; 2012 May; 29(5):1344-65. PubMed ID: 22222384
[TBL] [Abstract][Full Text] [Related]
10. PK11195-chitosan-graft-polyethylenimine-modified SPION as a mitochondria-targeting gene carrier.
Kim YK; Zhang M; Lu JJ; Xu F; Chen BA; Xing L; Jiang HL
J Drug Target; 2016; 24(5):457-67. PubMed ID: 26390926
[TBL] [Abstract][Full Text] [Related]
11. Preparation and characterization of superparamagnetic iron oxide nanoparticles for magnetically guided drug delivery.
Kumar P; Agnihotri S; Roy I
Int J Nanomedicine; 2018; 13(T-NANO 2014 Abstracts):43-46. PubMed ID: 30880956
[TBL] [Abstract][Full Text] [Related]
12. Formation and characterization of β-cyclodextrin (β-CD) - polyethyleneglycol (PEG) - polyethyleneimine (PEI) coated Fe3O4 nanoparticles for loading and releasing 5-Fluorouracil drug.
Prabha G; Raj V
Biomed Pharmacother; 2016 May; 80():173-182. PubMed ID: 27133054
[TBL] [Abstract][Full Text] [Related]
13. Novel magnetic iron oxide nanoparticles coated with poly(ethylene imine)-g-poly(ethylene glycol) for potential biomedical application: synthesis, stability, cytotoxicity and MR imaging.
Schweiger C; Pietzonka C; Heverhagen J; Kissel T
Int J Pharm; 2011 Apr; 408(1-2):130-7. PubMed ID: 21315813
[TBL] [Abstract][Full Text] [Related]
14. Double-receptor-targeting multifunctional iron oxide nanoparticles drug delivery system for the treatment and imaging of prostate cancer.
Ahmed MSU; Salam AB; Yates C; Willian K; Jaynes J; Turner T; Abdalla MO
Int J Nanomedicine; 2017; 12():6973-6984. PubMed ID: 29033565
[TBL] [Abstract][Full Text] [Related]
15. Polyethylenimine-based theranostic nanoplatform for glioma-targeting single-photon emission computed tomography imaging and anticancer drug delivery.
Zhao L; Zhu J; Gong J; Song N; Wu S; Qiao W; Yang J; Zhu M; Zhao J
J Nanobiotechnology; 2020 Oct; 18(1):143. PubMed ID: 33054757
[TBL] [Abstract][Full Text] [Related]
16. Polyethyleneimine-mediated synthesis of folic acid-targeted iron oxide nanoparticles for in vivo tumor MR imaging.
Li J; Zheng L; Cai H; Sun W; Shen M; Zhang G; Shi X
Biomaterials; 2013 Nov; 34(33):8382-92. PubMed ID: 23932250
[TBL] [Abstract][Full Text] [Related]
17. Development of a magnetic nano-graphene oxide carrier for improved glioma-targeted drug delivery and imaging: In vitro and in vivo evaluations.
Shirvalilou S; Khoei S; Khoee S; Raoufi NJ; Karimi MR; Shakeri-Zadeh A
Chem Biol Interact; 2018 Nov; 295():97-108. PubMed ID: 30170108
[TBL] [Abstract][Full Text] [Related]
18. Polyethyleneimine-mediated synthesis of superparamagnetic iron oxide nanoparticles with enhanced sensitivity in T2 magnetic resonance imaging.
Do MA; Yoon GJ; Yeum JH; Han M; Chang Y; Choi JH
Colloids Surf B Biointerfaces; 2014 Oct; 122():752-759. PubMed ID: 25194592
[TBL] [Abstract][Full Text] [Related]
19. Assembly of polyethylenimine-based magnetic iron oxide vectors: insights into gene delivery.
Arsianti M; Lim M; Marquis CP; Amal R
Langmuir; 2010 May; 26(10):7314-26. PubMed ID: 20112951
[TBL] [Abstract][Full Text] [Related]
20. Glioma selectivity of magnetically targeted nanoparticles: a role of abnormal tumor hydrodynamics.
Chertok B; David AE; Huang Y; Yang VC
J Control Release; 2007 Oct; 122(3):315-23. PubMed ID: 17628157
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
